bupropion has been researched along with Day Blindness in 2 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takusagawa, HL | 1 |
| Hunter, RS | 1 |
| Jue, A | 1 |
| Pasquale, LR | 1 |
| Chen, TC | 1 |
| Greenberg, WM | 1 |
2 other studies available for bupropion and Day Blindness
| Article | Year |
|---|---|
Bilateral uveal effusion and angle-closure glaucoma associated with bupropion use.
Topics: Adult; Bupropion; Depressive Disorder; Dopamine Uptake Inhibitors; Female; Glaucoma, Angle-Closure; | 2012 |
Visual field "shimmering" associated with nefazodone.
Topics: Bupropion; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Middle Aged; P | 1999 |